只使用免费官方源：SEC Forms 3/4/5 结构化内部人申报，以及 FINRA Consolidated NMS 场外卖空成交量。 两类数据均保留来源边界，不转写成买卖建议。
SEC 已完成季度 Forms 3/4/5 结构化历史基线 + EDGAR 当前季度 Form 4 增量；个股卡片仅展示当前自然季度的非衍生证券买卖代码 P/S（公开市场或私下交易），成交金额由股数 × 每股价格计算。
官方数据说明| 2026-06-30 2026-07-01 | PHVS Pharvaris N.V. | Lesage Anne Officer · Chief Early Development | 卖出（S） | 27,872 | US$35.48 | US$988,890.20 | 58,750 | SEC |
| 2026-06-30 2026-07-01 | PHVS Pharvaris N.V. | Schikan Johannes Gerardus Christiaan Petrus Director | 卖出（S） | 30,712 | US$35.49 | US$109万 | 315,167 | SEC |
| 2026-06-29 2026-07-01 | PHVS Pharvaris N.V. | Lesage Anne Officer · Chief Early Development | 卖出（S） | 2,300 | US$35.12 | US$80,785.66 | 56,450 | SEC |
| 2026-06-29 2026-07-01 | PHVS Pharvaris N.V. | Lesage Anne Officer · Chief Early Development | 卖出（S） | 8,300 | US$35.05 | US$290,907.53 | 58,750 | SEC |
| 2026-06-29 2026-07-01 | PHVS Pharvaris N.V. | Lesage Anne Officer · Chief Early Development | 卖出（S） | 6,997 | US$35.05 | US$245,231.56 | 124,672 | SEC |
| 2026-06-29 2026-07-01 | PHVS Pharvaris N.V. | Schikan Johannes Gerardus Christiaan Petrus Director | 卖出（S） | 6,888 | US$35.05 | US$241,447.13 | 345,879 | SEC |
| 2026-06-29 2026-06-29 | PHVS Pharvaris N.V. | Schikan Johannes Gerardus Christiaan Petrus Director | 卖出（S） | 2,400 | US$35.10 | US$84,240.00 | 352,767 | SEC |
| 2026-06-26 2026-06-29 | PHVS Pharvaris N.V. | Lu Peng Officer · Chief Medical Officer | 卖出（S） | 14,700 | US$34.00 | US$499,800.00 | 65,631 | SEC |
| 2026-06-25 2026-06-29 | PHVS Pharvaris N.V. | Lu Peng Officer · Chief Medical Officer | 卖出（S） | 3,400 | US$35.09 | US$119,306.00 | 65,631 | SEC |
| 2026-06-25 2026-06-29 | PHVS Pharvaris N.V. | Lu Peng Officer · Chief Medical Officer | 卖出（S） | 11,600 | US$34.45 | US$399,620.00 | 69,031 | SEC |
| 2026-06-25 2026-06-29 | PHVS Pharvaris N.V. | Lesage Anne Officer · Chief Early Development | 卖出（S） | 2,300 | US$35.12 | US$80,776.00 | 56,450 | SEC |
| 2026-06-25 2026-06-29 | PHVS Pharvaris N.V. | Lesage Anne Officer · Chief Early Development | 卖出（S） | 2,300 | US$35.12 | US$80,776.00 | 131,669 | SEC |
| 2026-06-18 2026-06-23 | PHVS Pharvaris N.V. | Lu Peng Officer · Chief Medical Officer | 卖出（S） | 300 | US$34.00 | US$10,200.00 | 65,631 | SEC |
| 2026-06-15 2026-06-17 | PHVS Pharvaris N.V. | Modig Berndt Director,Officer · Chief Executive Officer | 卖出（S） | 100 | US$31.46 | US$3,146.00 | 135,209 | SEC |
| 2026-06-15 2026-06-17 | PHVS Pharvaris N.V. | Modig Berndt Director,Officer · Chief Executive Officer | 卖出（S） | 2,191 | US$31.05 | US$68,030.55 | 135,309 | SEC |
| 2026-06-04 2026-06-08 | PHVS Pharvaris N.V. | Nijdam Anna Officer · Principal Accounting Officer | 卖出（S） | 2,670 | US$30.87 | US$82,422.90 | 46,275 | SEC |
| 2026-05-22 2026-05-26 | PHVS Pharvaris N.V. | Nijdam Anna Officer · Principal Accounting Officer | 卖出（S） | 5,501 | US$30.74 | US$169,100.74 | 48,945 | SEC |
| 2026-05-21 2026-05-26 | PHVS Pharvaris N.V. | Nassif David W. Officer · CFO / CLO | 卖出（S） | 10,000 | US$30.31 | US$303,100.00 | 120,300 | SEC |
| 2026-05-21 2026-05-26 | PHVS Pharvaris N.V. | Nijdam Anna Officer · Principal Accounting Officer | 卖出（S） | 1,829 | US$30.60 | US$55,967.40 | 48,945 | SEC |
| 2026-05-21 2026-05-26 | PHVS Pharvaris N.V. | Monges Viviane Director | 卖出（S） | 9,667 | US$30.29 | US$292,813.43 | 5,500 | SEC |
| 2026-05-20 2026-05-22 | PHVS Pharvaris N.V. | Bjork Elisabeth Director | 卖出（S） | 10,000 | US$29.32 | US$293,200.00 | 15,167 | SEC |
| 2026-05-18 2026-05-20 | PHVS Pharvaris N.V. | Modig Berndt Director,Officer · Chief Executive Officer | 卖出（S） | 2,292 | US$29.22 | US$66,972.24 | 137,500 | SEC |
| 2026-05-15 2026-05-19 | PHVS Pharvaris N.V. | Souverijns Wim Officer · Chief Commercial Officer | 卖出（S） | 10,000 | US$29.92 | US$299,200.00 | 45,111 | SEC |
| 2026-05-15 2026-05-19 | PHVS Pharvaris N.V. | Abele Stefan Andreas Officer · Chief Technical Ops Officer | 卖出（S） | 8,748 | US$29.82 | US$260,865.36 | 35,194 | SEC |
| 2026-05-15 2026-05-19 | PHVS Pharvaris N.V. | Glassman Robert Director | 卖出（S） | 5,333 | US$29.83 | US$159,083.39 | 15,167 | SEC |
| 2026-05-15 2026-05-19 | PHVS Pharvaris N.V. | Glassman Robert Director | 卖出（S） | 4,667 | US$29.82 | US$139,169.94 | 10,500 | SEC |
| 2026-05-01 2026-05-05 | PHVS Pharvaris N.V. | Lu Peng Officer · Chief Medical Officer | 卖出（S） | 14,023 | US$30.16 | US$422,933.68 | 66,226 | SEC |
| 2026-05-01 2026-05-05 | PHVS Pharvaris N.V. | Lu Peng Officer · Chief Medical Officer | 卖出（S） | 143 | US$31.00 | US$4,433.00 | 66,083 | SEC |
| 2026-04-30 2026-05-01 | PHVS Pharvaris N.V. | Lu Peng Officer · Chief Medical Officer | 卖出（S） | 15,000 | US$30.24 | US$453,600.00 | 66,083 | SEC |
| 2026-04-30 2026-05-01 | PHVS Pharvaris N.V. | Lesage Anne Officer · Chief Early Development | 卖出（S） | 19,200 | US$30.26 | US$580,992.00 | 133,969 | SEC |
| 2026-04-30 2026-05-01 | PHVS Pharvaris N.V. | Lesage Anne Officer · Chief Early Development | 卖出（S） | 18,000 | US$30.26 | US$544,680.00 | 56,450 | SEC |
| 2026-04-30 2026-05-01 | PHVS Pharvaris N.V. | Lesage Anne Officer · Chief Early Development | 卖出（S） | 3,700 | US$30.26 | US$111,962.00 | 56,450 | SEC |
| 2026-04-30 2026-05-01 | PHVS Pharvaris N.V. | Schikan Johannes Gerardus Christiaan Petrus Director | 卖出（S） | 670 | US$31.03 | US$20,790.10 | 355,167 | SEC |
| 2026-04-30 2026-05-01 | PHVS Pharvaris N.V. | Schikan Johannes Gerardus Christiaan Petrus Director | 卖出（S） | 28,400 | US$30.30 | US$860,520.00 | 355,837 | SEC |
| 2026-04-29 2026-05-01 | PHVS Pharvaris N.V. | Lu Peng Officer · Chief Medical Officer | 卖出（S） | 3,733 | US$30.06 | US$112,213.98 | 62,350 | SEC |
| 2026-04-29 2026-05-01 | PHVS Pharvaris N.V. | Lesage Anne Officer · Chief Early Development | 卖出（S） | 3,700 | US$30.08 | US$111,296.00 | 56,450 | SEC |
| 2026-04-29 2026-05-01 | PHVS Pharvaris N.V. | Lesage Anne Officer · Chief Early Development | 卖出（S） | 3,700 | US$30.06 | US$111,222.00 | 153,169 | SEC |
| 2026-04-29 2026-05-01 | PHVS Pharvaris N.V. | Schikan Johannes Gerardus Christiaan Petrus Director | 卖出（S） | 3,830 | US$30.07 | US$115,168.10 | 384,237 | SEC |
| 2026-04-23 2026-04-24 | PHVS Pharvaris N.V. | Lu Peng Officer · Chief Medical Officer | 卖出（S） | 100 | US$30.03 | US$3,003.00 | 66,083 | SEC |
| 2026-04-23 2026-04-24 | PHVS Pharvaris N.V. | Lesage Anne Officer · Chief Early Development | 卖出（S） | 100 | US$30.03 | US$3,003.00 | 56,450 | SEC |
| 2026-04-23 2026-04-24 | PHVS Pharvaris N.V. | Lesage Anne Officer · Chief Early Development | 卖出（S） | 100 | US$30.03 | US$3,003.00 | 156,869 | SEC |
| 2026-04-23 2026-04-24 | PHVS Pharvaris N.V. | Schikan Johannes Gerardus Christiaan Petrus Director | 卖出（S） | 100 | US$30.03 | US$3,003.00 | 388,067 | SEC |
| 2026-04-22 2026-04-24 | PHVS Pharvaris N.V. | Lu Peng Officer · Chief Medical Officer | 卖出（S） | 7,001 | US$30.05 | US$210,380.05 | 66,083 | SEC |
| 2026-04-22 2026-04-24 | PHVS Pharvaris N.V. | Lesage Anne Officer · Chief Early Development | 卖出（S） | 7,000 | US$30.05 | US$210,350.00 | 56,450 | SEC |
| 2026-04-22 2026-04-24 | PHVS Pharvaris N.V. | Lesage Anne Officer · Chief Early Development | 卖出（S） | 7,000 | US$30.05 | US$210,350.00 | 156,969 | SEC |
| 2026-04-22 2026-04-24 | PHVS Pharvaris N.V. | Lesage Anne Officer · Chief Early Development | 卖出（S） | 500 | US$30.00 | US$15,000.00 | 56,450 | SEC |
| 2026-04-22 2026-04-24 | PHVS Pharvaris N.V. | Schikan Johannes Gerardus Christiaan Petrus Director | 卖出（S） | 7,000 | US$30.05 | US$210,350.00 | 388,167 | SEC |
| 2026-04-16 2026-04-20 | PHVS Pharvaris N.V. | Modig Berndt Director,Officer · Chief Executive Officer | 卖出（S） | 2,292 | US$28.60 | US$65,551.20 | 139,792 | SEC |
| 2026-04-09 2026-04-10 | PHVS Pharvaris N.V. | Modig Berndt Director,Officer · Chief Executive Officer | 卖出（S） | 23,133 | US$27.74 | US$641,709.42 | 142,284 | SEC |
| 2026-04-09 2026-04-10 | PHVS Pharvaris N.V. | Modig Berndt Director,Officer · Chief Executive Officer | 卖出（S） | 200 | US$28.42 | US$5,684.00 | 142,084 | SEC |
| 代码 | 卖空成交量 | 豁免卖空量 | 场外总成交量 | 卖空量占比 | 报告设施 |
|---|---|---|---|---|---|
| PHVS | 75,961.9814 | 0 | 252,837.4136 | 30.04% | B, Q, N |